CLSI M24-A2
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2011
- Comments Off on CLSI M24-A2
- CLSI
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24A2E
standard by Clinical and Laboratory Standards Institute, 03/01/2011
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline–Second Edition, M44A2
standard by Clinical and Laboratory Standards Institute, 05/01/2009
Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second Informational Supplement,VET03VET04S1E
standard by Clinical and Laboratory Standards Institute, 09/01/2014
Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns, 2nd Edition, NBS03Ed2E
standard by Clinical and Laboratory Standards Institute, 08/07/2019
Performance Standards for Antifungal Disk Diffusion SusceptibilityTesting of Filamentous Fungi; Informational Supplement
standard by Clinical and Laboratory Standards Institute, 06/01/2009
Quality Management System: Equipment; Approved Guideline, QMS13AE
standard by Clinical and Laboratory Standards Institute, 08/01/2011
Training and Competence Assessment; Approved Guideline–Fourth Edition; QMS03Ed4E
standard by Clinical and Laboratory Standards Institute, 12/01/2016
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard – Eighth Edition, M11A8E
standard by Clinical and Laboratory Standards Institute, 02/01/2012